Helmut Bittiger

Title: Helmut Bittiger: Innovator in GABA Receptor Research

Introduction

Helmut Bittiger is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmacology, particularly in the study of GABA receptors. With a total of 6 patents to his name, Bittiger's work has implications for the treatment of various neurological disorders.

Latest Patents

Bittiger's latest patents include innovations related to purified GABA receptors and receptor proteins derived from both rat and human sources. These patents provide methods for isolating other members of the GABA receptor family using DNA cloning technology. Additionally, he has developed substituted propane-phosphinic acid compounds that exhibit GABA_B-antagonistic properties, which can be utilized as pharmacological agents.

Career Highlights

Throughout his career, Helmut Bittiger has worked with prominent companies such as Ciba-Geigy Corporation and Novartis AG. His research has focused on the identification and characterization of compounds that modulate GABA receptor activity, which is crucial for understanding and treating disorders associated with the central and peripheral nervous systems.

Collaborations

Bittiger has collaborated with notable colleagues in his field, including Stuart J. Mickel and Eric K. Baylis. These partnerships have contributed to the advancement of research in GABA receptor pharmacology.

Conclusion

Helmut Bittiger's innovative work in GABA receptor research has led to significant advancements in pharmacology. His contributions continue to influence the development of treatments for neurological disorders.